178 related articles for article (PubMed ID: 26945359)
21. MicroRNA-223 and microRNA-92a in stool and plasma samples act as complementary biomarkers to increase colorectal cancer detection.
Chang PY; Chen CC; Chang YS; Tsai WS; You JF; Lin GP; Chen TW; Chen JS; Chan EC
Oncotarget; 2016 Mar; 7(9):10663-75. PubMed ID: 26848774
[TBL] [Abstract][Full Text] [Related]
22. A plasma microRNA panel for early detection of colorectal cancer.
Wang S; Xiang J; Li Z; Lu S; Hu J; Gao X; Yu L; Wang L; Wang J; Wu Y; Chen Z; Zhu H
Int J Cancer; 2015 Jan; 136(1):152-61. PubMed ID: 23456911
[TBL] [Abstract][Full Text] [Related]
23. Fecal Occult Blood Tests in Colorectal Cancer Screening: Systematic Review and Meta-analysis of Traditional and New-generation Fecal Immunochemical Tests.
Meklin J; SyrjÄnen K; Eskelinen M
Anticancer Res; 2020 Jul; 40(7):3591-3604. PubMed ID: 32620599
[TBL] [Abstract][Full Text] [Related]
24. Identification of microRNAs as diagnostic biomarkers in screening of head and neck cancer: a meta-analysis.
Zhang M; Zhao LJ; Liang WQ; Mao ZP
Genet Mol Res; 2015 Dec; 14(4):16562-76. PubMed ID: 26681002
[TBL] [Abstract][Full Text] [Related]
25. Clinical utilization of serum- or plasma-based miRNAs as early detection biomarkers for pancreatic cancer: A meta-analysis up to now.
Wei L; Yao K; Gan S; Suo Z
Medicine (Baltimore); 2018 Aug; 97(35):e12132. PubMed ID: 30170450
[TBL] [Abstract][Full Text] [Related]
26. The accuracy of circulating microRNA-21 in the diagnosis of colorectal cancer: a systematic review and meta-analysis.
Xu F; Xu L; Wang M; An G; Feng G
Colorectal Dis; 2015 May; 17(5):O100-7. PubMed ID: 25683351
[TBL] [Abstract][Full Text] [Related]
27. Circulating microRNA-21 as a biomarker for the detection of various carcinomas: an updated meta-analysis based on 36 studies.
Wu K; Li L; Li S
Tumour Biol; 2015 Mar; 36(3):1973-81. PubMed ID: 25527152
[TBL] [Abstract][Full Text] [Related]
28. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.
Chen WY; Zhao XJ; Yu ZF; Hu FL; Liu YP; Cui BB; Dong XS; Zhao YS
Int J Clin Exp Pathol; 2015; 8(6):7092-101. PubMed ID: 26261602
[TBL] [Abstract][Full Text] [Related]
29. Faecal microRNAs as a non-invasive tool in the diagnosis of colonic adenomas and colorectal cancer: A meta-analysis.
Yau TO; Tang CM; Harriss EK; Dickins B; Polytarchou C
Sci Rep; 2019 Jul; 9(1):9491. PubMed ID: 31263200
[TBL] [Abstract][Full Text] [Related]
30. Identification of circulating microRNAs as biomarkers in diagnosis of hematologic cancers: a meta-analysis.
Li Q; Liu L; Li W
Tumour Biol; 2014 Oct; 35(10):10467-78. PubMed ID: 25053601
[TBL] [Abstract][Full Text] [Related]
31. Clinically relevant circulating microRNA profiling studies in pancreatic cancer using meta-analysis.
Pei Z; Liu SM; Huang JT; Zhang X; Yan D; Xia Q; Ji C; Chen W; Zhang X; Xu J; Wang J
Oncotarget; 2017 Apr; 8(14):22616-22624. PubMed ID: 28186984
[TBL] [Abstract][Full Text] [Related]
32. Value of Blood-Based microRNAs in the Diagnosis of Acute Myocardial Infarction: A Systematic Review and Meta-Analysis.
Zhai C; Li R; Hou K; Chen J; Alzogool M; Hu Y; Zhang J; Zhang Y; Wang L; Zhang R; Cong H
Front Physiol; 2020; 11():691. PubMed ID: 32922300
[No Abstract] [Full Text] [Related]
33. MicroRNAs as Biomarkers for the Diagnostics of Bladder Cancer: a Meta-Analysis.
Chen L; Cui Z; Liu Y; Bai Y; Lan F
Clin Lab; 2015; 61(8):1101-8. PubMed ID: 26427157
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic Accuracy of Fecal Immunochemical Test in Patients at Increased Risk for Colorectal Cancer: A Meta-analysis.
Katsoula A; Paschos P; Haidich AB; Tsapas A; Giouleme O
JAMA Intern Med; 2017 Aug; 177(8):1110-1118. PubMed ID: 28628706
[TBL] [Abstract][Full Text] [Related]
35. Insights into the potential use of microRNAs as a novel class of biomarkers in esophageal cancer.
Wan J; Wu W; Che Y; Kang N; Zhang R
Dis Esophagus; 2016 Jul; 29(5):412-20. PubMed ID: 25789723
[TBL] [Abstract][Full Text] [Related]
36. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
[TBL] [Abstract][Full Text] [Related]
37. Circulating miRNAs as Novel Diagnostic Biomarkers in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
Cai C; Lin Y; Yu C
Can J Gastroenterol Hepatol; 2019; 2019():2096161. PubMed ID: 31531307
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic significance of circulating miRNAs in systemic lupus erythematosus.
Zheng X; Zhang Y; Yue P; Liu L; Wang C; Zhou K; Hua Y; Wu G; Li Y
PLoS One; 2019; 14(6):e0217523. PubMed ID: 31163082
[TBL] [Abstract][Full Text] [Related]
39. Extracellular vesicle biomarkers in circulation for colorectal cancer detection: a systematic review and meta-analysis.
Shi X; Zhao X; Xue J; Jia E
BMC Cancer; 2024 May; 24(1):623. PubMed ID: 38778252
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic performance of urine and blood microRNAs for bladder cancer: a meta-analysis.
Ye Q; Wang J; Xu D; Liu Y; Zhang D; Ye J; Li H
Expert Rev Anticancer Ther; 2022 Dec; 22(12):1357-1369. PubMed ID: 36374119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
